Sharechat Logo

Vital Healthcare flags A$84 mln spend to expand Australian portfolio

Wednesday 1st June 2016

Text too small?

Vital Healthcare, which owns and develops property for hospitals and healthcare providers, plans to spend A$84 million to expand existing operations across the Tasman and make a series of new acquisitions.

The unit trust's manager, Vital Healthcare Management, said it will spend A$64 million on brownfield developments for its Australian hospital portfolio and a further A$20 million has been earmarked for "strategic acquisitions" to enhance its existing assets. Once completed, Vital anticipates the spending will raise the quality of its property portfolio and lift earnings. 

"This suite of value and earnings enhancing projects highlights the continued growth in demand for healthcare services provided by market leading operators across our portfolio," chief executive David Carr said in a statement. "We expect to see more of these organic opportunities over time." 

Vital is betting on a strong long-term outlook for the healthcare sector, buying properties on both sides of the Tasman which have similar demographics with ageing populations in need of medical services. 

The property investor's project pipeline includes a A$23.6 million development of its Lingard Private Hospital in Newcastle to boost capacity, A$22.4 million to expand Maitland Private Hospital in East Maitland, New South Wales, A$9.9 million to add mental health and rehabilitation services at Toronto Private Hospital in Toronto, NSW, and A$3.7 million to modernise Dubbo Private Hospital in NSW. Vital has also flagged A$4.5 million to build another operating theatre at Epworth Eastern Hospital in Box Hill, Victoria. 

The units increased 0.2 percent to $2.26 and have gained 21 percent this year. The stock is rated an average 'sell' based on four analyst recommendations compiled by Reuters with a median target price of $1.98.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

CEN - Contact Chair to retire this year, new Chair appointed
May 1st Morning Report
GTK - Gentrack's Veovo Acquires Dubai Technology Partners
SML - Additional information following Bright Dairy announcement
April 30th Morning Report
Rua Bioscience Market Update
FSF - Fonterra announces interim leadership changes
April 29th Morning Report
NZK - Blue Endeavour Pilot Farm and Wellboat Update
TRU - FY 31 March 2026 Revenue and Results Guidance Achieved